Austria-based ImageBiopsy Lab has partnered with Danish company Radiobotics to implement artificial intelligence (AI) assisted disease diagnostics in the Germany, Austria, and Switzerland (DACH) region.

The use of AI in assisting disease diagnostics has increased in recent years. According to a report by GlobalData, the AI market will be worth $93bn this year. The analysis also identifies AI-assisted radiology as an emerging and disruptive technology that should be tracked closely, with Dutch conglomerate Philips being one of the leading patent filers in AI-assisted CT imaging.

According to ImageBiopsy Lab and Radiobotics, their AI-assisted technology will support disease diagnosis in musculoskeletal, orthopaedic, and trauma use cases. The technology is expected to reduce the manual interpretation of X-rays and MRI images, thereby increasing efficiency.

The technology will analyse imaging and conduct any measurement and scoring to help in interpretation and reduce manual load. It could also help with fracture detection workflow.

“Before even considering the use of AI, it’s crucial to grasp physicians’ diagnostic workflow and needs,” said ImageBiopsy Lab CEO Dr Richard Ljuhar.

“For this purpose, we’ve closely collaborated with leading musculoskeletal radiologists, orthopaedics, and traumatologists over the past years.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

ImageBiopsy has a US Food and Drug Administration (FDA)-approved radiological image processing software, IB Lab LAMA. It provides limb and angle measurements on leg X-rays, which can used by orthopaedic surgeons to manage their patients.

The other products in the company’s catalogue include IB Lab KOALA, which can detect signs of knee osteoarthritis using joint measurements; and IB Lab SQUIRREL module for scoliosis assessment.

Radiobotics has a fracture detection AI software, RBfracture, which highlights the possible fracture locations in each X-ray therapy, thereby reducing the time to analyse, especially in trauma settings.